XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument 9HJ SE0018040784 CINIS FERTILIZER AB EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument 9HJ SE0018040784 CINIS FERTILIZER AB EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument PGO0 SE0023261532 PROSTATYPE GENOMICS AB EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument PGO0 SE0023261532 PROSTATYPE GENOMICS AB EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument 76D FR0010844464 MEDESIS PHARMA IL EO 2,- EQUITY wird ex Kapitalmassnahme gehandelt am 15.05.2025
The instrument 76D FR0010844464 MEDESIS PHARMA IL EO 2,- EQUITY is traded ex capital adjustment on 15.05.2025

Das Instrument 9H0 FI4000233317 ENERSIZE OYJ EQUITY wird ex Kapitalmassnahme gehandelt am 15.05.2025
The instrument 9H0 FI4000233317 ENERSIZE OYJ EQUITY is traded ex capital adjustment on 15.05.2025

Das Instrument E2Z ES0157097017 ALMIRALL S.A. EO -,12 EQUITY wird ex Kapitalmassnahme gehandelt am 15.05.2025
The instrument E2Z ES0157097017 ALMIRALL S.A. EO -,12 EQUITY is traded ex capital adjustment on 15.05.2025

Das Instrument Z0Y US46982L1089 JACOBS SOLUTIONS INC. DL1 EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument Z0Y US46982L1089 JACOBS SOLUTIONS INC. DL1 EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument DEVL SG1L01001701 DBS GRP HLDGS SD 1 EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument DEVL SG1L01001701 DBS GRP HLDGS SD 1 EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument AF8 NO0003078107 AF GRUPPEN ASA A NK 0,05 EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument AF8 NO0003078107 AF GRUPPEN ASA A NK 0,05 EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument MX7A HK0200030994 MELCO INTL SUBDIV. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument MX7A HK0200030994 MELCO INTL SUBDIV. EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Solarbranche vor dem Mega-Comeback?

Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:

Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
hina bremst Preisdumping & pusht massiv den Ausbau

Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!

Hier klicken

Zeit	Aktuelle Nachrichten
13:29	AF Gruppen ASA: Constructing office building in Raufoss
Do	AF Gruppen ASA: Mandatory notification of trades
Do	AF Gruppen ASA: Share issue and sale of shares
Di	AF Gruppen ASA: Selected for project at the new Aker Hospital
Mo	AF Gruppen ASA: Contract Awarded by the Swedish Fortifications Agency

Zeit

Aktuelle Nachrichten

13:29

AF Gruppen ASA: Constructing office building in Raufoss

AF Gruppen ASA: Mandatory notification of trades

AF Gruppen ASA: Share issue and sale of shares

AF Gruppen ASA: Selected for project at the new Aker Hospital

AF Gruppen ASA: Contract Awarded by the Swedish Fortifications Agency

Zeit	Aktuelle Nachrichten
29.09.	Neither Grifols, Rovi nor Almirall to be significantly affected by tariffs on pharmaceutical sector
18.09.	Almirall, S.A.: Almirall Presents Long-Term Results from First Real-World Dermatology Study Using WHO-5 Well-Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025	Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults... ► Artikel lesen
17.09.	Almirall, S.A.: EADV 2025: Almirall Advances Skin Science and Leads Innovation for Holistic Patient Care in Medical Dermatology	Almirall's scientific presence at the 34th EADV congress reflects its broad portfolio of dermatological treatments and patient-centric approach featuring 44 abstracts, two expert-led symposia... ► Artikel lesen
26.08.	Almirall and Absci expand AI dermatological drug discovery partnership
07.08.	Absci Corporation: Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target	Almirall selects second target in AI Drug Creation collaborationExpanded collaboration builds on Absci's successful de novo molecule design for difficult-to-drug targets in the first stage of the... ► Artikel lesen

Zeit

Aktuelle Nachrichten

29.09.

Neither Grifols, Rovi nor Almirall to be significantly affected by tariffs on pharmaceutical sector

18.09.

Almirall, S.A.: Almirall Presents Long-Term Results from First Real-World Dermatology Study Using WHO-5 Well-Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025

Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults...
► Artikel lesen

17.09.

Almirall, S.A.: EADV 2025: Almirall Advances Skin Science and Leads Innovation for Holistic Patient Care in Medical Dermatology

Almirall's scientific presence at the 34th EADV congress reflects its broad portfolio of dermatological treatments and patient-centric approach featuring 44 abstracts, two expert-led symposia...
► Artikel lesen

26.08.

Almirall and Absci expand AI dermatological drug discovery partnership

07.08.

Absci Corporation: Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Almirall selects second target in AI Drug Creation collaborationExpanded collaboration builds on Absci's successful de novo molecule design for difficult-to-drug targets in the first stage of the...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Do	Cinis Fertilizer AB: Cinis Fertilizer removes operational goal and initiates strategic review	The board and management of Cinis Fertilizer have decided to remove current target of reaching the production rate of 100,000 tons of potassium sulfate by the end of the year. The decision is made after... ► Artikel lesen
11.09.	Cinis Fertilizer AB: Cinis Fertilizer increases its production of environmentally friendly mineral fertilizer	During August 2025, Cinis Fertilizer produced approximately 5.5 thousand tons of water-soluble potassium sulfate at its plant in Köpmanholmen outside Örnsköldsvik, Sweden. The production volume of mineral... ► Artikel lesen
21.08.	Cinis Fertilizer AB: Interim report for the period January 1 - June 30, 2025	Focus on increasing profitability With financing secured and increased production in the second quarter, Cinis Fertilizer will focus on further increasing its profitability. This includes driving actions... ► Artikel lesen
28.07.	Cinis Fertilizer AB: Cinis delivers 4,900 tons of potassium sulfate	Cinis Fertilizer has shipped full cargo of water-soluble potassium sulfate from the production facility in Örnsköldsvik, Sweden, to its customer Van Iperen International in the Netherlands. The cargo... ► Artikel lesen
30.06.	Cinis Fertilizer AB: Cinis delivers an additional 4,600 tons of potassium sulfate	Cinis Fertilizer has sent another shipload of water-soluble potassium sulfate to its customer Van Iperen International. The cargo amounts to approximately 4,600 tons. The next shipload of water-soluble... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Cinis Fertilizer AB: Cinis Fertilizer removes operational goal and initiates strategic review

The board and management of Cinis Fertilizer have decided to remove current target of reaching the production rate of 100,000 tons of potassium sulfate by the end of the year. The decision is made after...
► Artikel lesen

11.09.

Cinis Fertilizer AB: Cinis Fertilizer increases its production of environmentally friendly mineral fertilizer

During August 2025, Cinis Fertilizer produced approximately 5.5 thousand tons of water-soluble potassium sulfate at its plant in Köpmanholmen outside Örnsköldsvik, Sweden. The production volume of mineral...
► Artikel lesen

21.08.

Cinis Fertilizer AB: Interim report for the period January 1 - June 30, 2025

Focus on increasing profitability With financing secured and increased production in the second quarter, Cinis Fertilizer will focus on further increasing its profitability. This includes driving actions...
► Artikel lesen

28.07.

Cinis Fertilizer AB: Cinis delivers 4,900 tons of potassium sulfate

Cinis Fertilizer has shipped full cargo of water-soluble potassium sulfate from the production facility in Örnsköldsvik, Sweden, to its customer Van Iperen International in the Netherlands. The cargo...
► Artikel lesen

30.06.

Cinis Fertilizer AB: Cinis delivers an additional 4,600 tons of potassium sulfate

Cinis Fertilizer has sent another shipload of water-soluble potassium sulfate to its customer Van Iperen International. The cargo amounts to approximately 4,600 tons. The next shipload of water-soluble...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Mi	DBS' Tan Su Shan tops Fortune's most powerful women in Asia list
Di	How DBS CEO Tan Su Shan is Crafting a Gen-AI Powerhouse
02.10.	DBS GROUP HOLDINGS LTD: COUPON PAYMENT::MANDATORY
26.09.	DBS turns bullish on Baidu, citing AI-driven cloud and robotaxi gains
23.09.	DBS-backed family-office platform hits $780-M assets, to double by end-2026

Zeit

Aktuelle Nachrichten

DBS' Tan Su Shan tops Fortune's most powerful women in Asia list

How DBS CEO Tan Su Shan is Crafting a Gen-AI Powerhouse

02.10.

DBS GROUP HOLDINGS LTD: COUPON PAYMENT::MANDATORY

26.09.

DBS turns bullish on Baidu, citing AI-driven cloud and robotaxi gains

23.09.

DBS-backed family-office platform hits $780-M assets, to double by end-2026

Zeit	Aktuelle Nachrichten
03.10.	Enersize Oyj: Enersize and Pure Positioning AB agree on commercial terms for acquisition - transaction concluded at a premium price	Enersize Oyj ("Enersize" or the "Company") and Pure Positioning AB (publ) ("PPAB") have today signed an addendum to the previously announced Letter of Intent ("LOI"), originally disclosed on 1 September... ► Artikel lesen
23.09.	Enersize Oyj: Enersize informs: Pure Positioning AB acquires the SveBorr Group	On 1 September 2025, Enersize announced that the Company had entered into a Letter of Intent (LOI) with Pure Positioning AB (publ) ("PPAB") regarding a potential acquisition of the company. PPAB has... ► Artikel lesen
18.09.	Enersize Oyj: Enersize informs: Pure Positioning AB acquires Iion AS	On September 1, 2025, Enersize Oyj ("Enersize") announced that the company had entered into a Letter of Intent ("LOI") with Pure Positioning AB (publ) ("PPAB") regarding a potential acquisition of the... ► Artikel lesen
17.09.	Enersize Oyj: Enersize receives repeat order from Swedish industrial customer - energy savings in EX-classified environment	Enersize has received a new order from a Swedish industrial company for leak detection in the compressed air system at one of the company's production facilities. The work, which will partly take place... ► Artikel lesen
17.09.	Enersize Oyj: Enersize takes the next step in the acquisition of PPAB and secures financing for the process	Enersize has today entered into a loan agreement with Pure Positioning AB, the counterparty in the Letter of Intent (LOI) announced on 1 September 2025. The loan facility amounts to a total of SEK 1... ► Artikel lesen

Zeit

Aktuelle Nachrichten

03.10.

Enersize Oyj: Enersize and Pure Positioning AB agree on commercial terms for acquisition - transaction concluded at a premium price

Enersize Oyj ("Enersize" or the "Company") and Pure Positioning AB (publ) ("PPAB") have today signed an addendum to the previously announced Letter of Intent ("LOI"), originally disclosed on 1 September...
► Artikel lesen

23.09.

Enersize Oyj: Enersize informs: Pure Positioning AB acquires the SveBorr Group

On 1 September 2025, Enersize announced that the Company had entered into a Letter of Intent (LOI) with Pure Positioning AB (publ) ("PPAB") regarding a potential acquisition of the company. PPAB has...
► Artikel lesen

18.09.

Enersize Oyj: Enersize informs: Pure Positioning AB acquires Iion AS

On September 1, 2025, Enersize Oyj ("Enersize") announced that the company had entered into a Letter of Intent ("LOI") with Pure Positioning AB (publ) ("PPAB") regarding a potential acquisition of the...
► Artikel lesen

17.09.

Enersize Oyj: Enersize receives repeat order from Swedish industrial customer - energy savings in EX-classified environment

Enersize has received a new order from a Swedish industrial company for leak detection in the compressed air system at one of the company's production facilities. The work, which will partly take place...
► Artikel lesen

17.09.

Enersize Oyj: Enersize takes the next step in the acquisition of PPAB and secures financing for the process

Enersize has today entered into a loan agreement with Pure Positioning AB, the counterparty in the Letter of Intent (LOI) announced on 1 September 2025. The loan facility amounts to a total of SEK 1...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Mi	Breaking Down Jacobs Solutions: 5 Analysts Share Their Views
30.09.	Jacobs Engineering Group outlook revised to positive by S&P Global
25.09.	Jacobs auf Goldman Sachs Forum: Strategien für effizientes Wassermanagement
19.09.	How Is Jacobs Solutions' Stock Performance Compared to Other Infrastructure Stocks?
17.09.	Jacobs Leads Infrastructure Design in Puerto Rico

Zeit

Aktuelle Nachrichten

Breaking Down Jacobs Solutions: 5 Analysts Share Their Views

30.09.

Jacobs Engineering Group outlook revised to positive by S&P Global

25.09.

Jacobs auf Goldman Sachs Forum: Strategien für effizientes Wassermanagement

19.09.

How Is Jacobs Solutions' Stock Performance Compared to Other Infrastructure Stocks?

17.09.

Jacobs Leads Infrastructure Design in Puerto Rico

Zeit	Aktuelle Nachrichten
15.05.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2025		The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2025.ISIN NameCA05259R1073 AUSTRALIS... ► Artikel lesen
15.05.	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025		Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen

Zeit

Aktuelle Nachrichten

15.05.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2025

The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2025.ISIN NameCA05259R1073 AUSTRALIS...
► Artikel lesen

15.05.

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

Zeit	Aktuelle Nachrichten
25.09.	MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REPLY FORM TO NEW REGISTERED SHAREHOLDERS
25.09.	MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS
25.09.	MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REQUEST FORM TO EXISTING REGISTERED SHAREHOLDERS
25.09.	MELCO INT'L DEV (00200): 2025 INTERIM REPORT
16.09.	MELCO INT'L DEV (00200): ANNOUNCEMENT - CONTINUING CONNECTED TRANSACTIONS

Zeit

Aktuelle Nachrichten

25.09.

MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REPLY FORM TO NEW REGISTERED SHAREHOLDERS

25.09.

MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS

25.09.

MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REQUEST FORM TO EXISTING REGISTERED SHAREHOLDERS

25.09.

MELCO INT'L DEV (00200): 2025 INTERIM REPORT

16.09.

MELCO INT'L DEV (00200): ANNOUNCEMENT - CONTINUING CONNECTED TRANSACTIONS

Zeit	Aktuelle Nachrichten
26.08.	Prostatype Genomics AB: Prostatype Genomics reaches important commercial breakthrough by initiating billing for Prostatype to insurance companies in the USA	Prostatype Genomics AB ("Prostatype Genomics" or the "Company") has reached an important commercial milestone in the USA by immediately starting to bill Prostatype® to several insurance companies. Prostatype®... ► Artikel lesen
23.07.	Prostatype Genomics AB: Prostatype Genomics publishes its interim report for the first half of 2025	Prostatype Genomics AB today publishes its interim report for the first half of 2025. The full interim report is attached and can also be downloaded from the company's website, www.prostatypegenomics.com. First... ► Artikel lesen
22.07.	Prostatype Genomics AB: Positive results for Prostatype confirmed in published Spanish multicentre study	Prostatype Genomics announces that previously communicated positive results from a Spanish multicentre study with Prostatype®, have now been confirmed in a scientific journal. The study included 93... ► Artikel lesen
03.06.	Prostatype Genomics AB: Strong results for Prostatype in published Taiwan study - creating opportunities for commercial expansion in Asia	Prostatype Genomics announces that strong results from a study in Taiwan with the company's prognostic genomic test Prostatype® have now been published in the scientific journal BJUI Compass. In the... ► Artikel lesen
15.05.	Prostatype Genomics AB: Prostatype Genomics updates on commercial progress in the U.S.	Prostatype Genomics announces that the company's commercial activities in the U.S. continue to develop in a positive way. The number of selected American urologists at urology clinics/hospitals who... ► Artikel lesen

Zeit

Aktuelle Nachrichten

26.08.

Prostatype Genomics AB: Prostatype Genomics reaches important commercial breakthrough by initiating billing for Prostatype to insurance companies in the USA

Prostatype Genomics AB ("Prostatype Genomics" or the "Company") has reached an important commercial milestone in the USA by immediately starting to bill Prostatype® to several insurance companies. Prostatype®...
► Artikel lesen

23.07.

Prostatype Genomics AB: Prostatype Genomics publishes its interim report for the first half of 2025

Prostatype Genomics AB today publishes its interim report for the first half of 2025. The full interim report is attached and can also be downloaded from the company's website, www.prostatypegenomics.com. First...
► Artikel lesen

22.07.

Prostatype Genomics AB: Positive results for Prostatype confirmed in published Spanish multicentre study

Prostatype Genomics announces that previously communicated positive results from a Spanish multicentre study with Prostatype®, have now been confirmed in a scientific journal. The study included 93...
► Artikel lesen

03.06.

Prostatype Genomics AB: Strong results for Prostatype in published Taiwan study - creating opportunities for commercial expansion in Asia

Prostatype Genomics announces that strong results from a study in Taiwan with the company's prognostic genomic test Prostatype® have now been published in the scientific journal BJUI Compass. In the...
► Artikel lesen

15.05.

Prostatype Genomics AB: Prostatype Genomics updates on commercial progress in the U.S.

Prostatype Genomics announces that the company's commercial activities in the U.S. continue to develop in a positive way. The number of selected American urologists at urology clinics/hospitals who...
► Artikel lesen

Zeit	Aktuelle Nachrichten
11.09.	R&S Group meldet starkes Q2-Wachstum 2025 und treibt Expansion in Europa voran
11.09.	R&S Group H1 2025 slides reveal 88% revenue surge as new CEO outlines strategy
11.09.	R&S Group hat Halbjahres-Gewinn mehr als verdoppelt	Sissach - Der Baselbieter Trafohersteller R&S hat im ersten Halbjahr 2025 den Gewinn mehr als verdoppelt. Das Unternehmen übertraf dabei die Erwartung der Analysten. Die Profitabilität ging wie angekündigt... ► Artikel lesen
11.09.	R&S Group hat Halbjahres-Gewinn mehr als verdoppelt - Erwartungen übertroffen
11.09.	Adhoc: R&S Group Holding AG: R&S Group with good operating performance in H1 2025	R&S Group Holding AG / Key word(s): Half Year Results R&S Group with good operating performance in H1 2025 11-Sep-2025 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art.... ► Artikel lesen

Zeit

Aktuelle Nachrichten

11.09.

R&S Group meldet starkes Q2-Wachstum 2025 und treibt Expansion in Europa voran

11.09.

R&S Group H1 2025 slides reveal 88% revenue surge as new CEO outlines strategy

11.09.

R&S Group hat Halbjahres-Gewinn mehr als verdoppelt

Sissach - Der Baselbieter Trafohersteller R&S hat im ersten Halbjahr 2025 den Gewinn mehr als verdoppelt. Das Unternehmen übertraf dabei die Erwartung der Analysten. Die Profitabilität ging wie angekündigt...
► Artikel lesen

11.09.

R&S Group hat Halbjahres-Gewinn mehr als verdoppelt - Erwartungen übertroffen

11.09.

Adhoc: R&S Group Holding AG: R&S Group with good operating performance in H1 2025

R&S Group Holding AG / Key word(s): Half Year Results R&S Group with good operating performance in H1 2025 11-Sep-2025 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art....
► Artikel lesen

Unternehmen / Aktien	Kurs	%
AF GRUPPEN ASA	14,660	-1,35 %
ALMIRALL SA	11,960	+0,34 %
CINIS FERTILIZER AB	0,025	-49,40 %
DBS GROUP HOLDINGS LTD	36,040	+0,59 %
ENERSIZE OYJ	0,000	0,00 %
JACOBS SOLUTIONS INC	134,00	-0,74 %
MEDESIS PHARMA SA	0,290	0,00 %
MELCO INTERNATIONAL DEVELOPMENT LTD	0,610	+1,67 %
PROSTATYPE GENOMICS AB	0,046	-6,53 %
R&S GROUP HOLDING AG	30,560	+1,53 %

Unternehmen / Aktien

Kurs

AF GRUPPEN ASA

14,660

-1,35 %

ALMIRALL SA

11,960

+0,34 %

CINIS FERTILIZER AB

0,025

-49,40 %

DBS GROUP HOLDINGS LTD